Apogee Therapeutics (APGE) Cash from Financing Activities (2022 - 2026)
Apogee Therapeutics (APGE) recorded Cash from Financing Activities of $107.02 million in Q2 2026, compared with $1.18 million a year earlier and down 74.0% from the prior quarter.
Powered by 
Analysis
Apogee Therapeutics (APGE) Cash from Financing Activities (2022 - 2026) Analysis & Trends
On a TTM basis, Apogee Therapeutics' Cash from Financing Activities came in at $912.87 million as of Jun 30, 2026; for FY2025, it came in at $396.49 million, down 19.9% from FY2024.
- Annual Cash from Financing Activities has a three-year compound annual growth rate of 33.1% (FY2022 to FY2025).
- Across earlier years, Cash from Financing Activities came in at $495.11 million in FY2024 (+57.0%), $315.39 million in FY2023 (+87.4%) and $168.32 million in FY2022.
- Quarterly Cash from Financing Activities has ranged from -$213,000 in Q4 2023 to $450.52 million in Q1 2024 over the past five years.
- Per Business Quant, the preceding three quarters came in at $411.17 million (Q1 2026), $374.95 million (Q4 2025) and $19.74 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Apogee Therapeutics | 10.18 Bn | 7.68 Bn | - | 107.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 107.02 Mn |
| Mar 31, 2026 | 411.17 Mn |
| Dec 31, 2025 | 374.95 Mn |
| Sep 30, 2025 | 19.74 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Mar 31, 2025 | 622,000.00 |
| Dec 31, 2024 | 44.36 Mn |
| Sep 30, 2024 | 383,000.00 |
| Jun 30, 2024 | -150,000.00 |
| Mar 31, 2024 | 450.52 Mn |
| Dec 31, 2023 | -213,000.00 |
| Sep 30, 2023 | 317.30 Mn |
| Dec 31, 2022 | 158.50 Mn |
| Sep 30, 2022 | 4.85 Mn |
API Access
Apogee Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=APGE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "APGE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=APGE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();